Aortic 18F-FDG PET/CT uptake pattern at 60 min (early) and 180 min (delayed) acquisition in a control population: A visual and semiquantitative comparative analysis

Nuclear Medicine Communications

Volumn 34, Issue 9, 2013, Pages 926-930

  Martínez Rodríguez, Isabel ^a   Del Castillo Matos, Rosangie ^a   Quirce, Remedios ^a   Banzo, Ignacio ^a   Jiménez Bonilla, Julio ^a   Martínez Amador, Nestor ^a   Ibáñez Bravo, Susana ^a   Lavado Pérez, Carmen ^a   Bravo Ferrer, Zully ^a   Carril, José M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

18F FDG PET CT; aortitis; blood pool; giant cell arteritis; large vessel vasculitis; positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AORTA WALL; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG UPTAKE; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; AORTA; AORTOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REFERENCE VALUE; SCINTISCANNING; STANDARDS; TIME; TRANSPORT AT THE CELLULAR LEVEL; METHODOLOGY; STANDARD;

AORTA; AORTOGRAPHY; BIOLOGICAL TRANSPORT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881498731     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32836370fb     Document Type: Article

References (23)

1. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology 1999; 38:444-447.
2. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108:246-249.
3. Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003; 30:730-736.
4. 18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32:674-681.
5. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55:131-137.
6. 18F-FDG PET/CT. Rev Esp Med Nucl 2012; 31:233-235.
7. 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012; 39:344-353.
8. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters. Br J Radiol 2012; 85:e188-e194.
9. 18F]- fluorodeoxyglucose positron emission tomography. Circulation 2002; 105:2708-2711.
10. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005; 36:2642-2647.
11. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006; 48:1818-1824.
12. 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 2007; 48:227-233.
13. 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med 2011; 52:1020-1027.
14. Quirce R, Mart́inez-Rodríguez I, De Arcocha Torres M, Jimé nez-Bonilla JF, Banzo I, Rebollo M, et al. Contribution of (18)F-sodium fluoride PET/CT to the study of the carotid atheroma calcification. Rev Esp Med Nucl Imagen Mol 2013; 32:22-25.
15. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61-77.
16. Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 2004; 24:1411-1431.
17. 18F-FDG PET/CT semiology. Rev Esp Med Nucl 2008; 27:284-304.
18. Chin BB, Green ED, Turkington TG, Hawk TC, Coleman RE. Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h. Mol Imaging Biol 2009; 11:118-122.
19. Cheng G, Alavi A, Lim E, Werner TJ, Del Bello CV, Akers SR. Dynamic changes of FDG uptake and clearance in normal tissues. Mol Imaging Biol 2013; 15:345-352.
20. 18F-FDG PET/CT: when to image? J Nucl Med 2009; 50:854-857.
21. 18F-FDG PET/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol 2013. doi:10.1016/j.remn.2012.12.004.
22. 18F-FDG PET/CT. J Nucl Med 2004; 45:1816-1821.
23. Chen W, Bural GG, Torigian DA, Rader DJ, Alavi A. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2009; 36:144-151.